

Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Non-small-cell lung carcinoma | D002289 | — | — | 9 | 30 | 15 | 1 | 14 | 65 |
| Lung neoplasms | D008175 | — | C34.90 | 8 | 26 | 8 | 1 | 6 | 45 |
| Neoplasms | D009369 | — | C80 | 4 | 2 | — | 1 | — | 5 |
| Carcinoma | D002277 | — | C80.0 | — | 1 | — | 1 | — | 2 |
| Adenocarcinoma | D000230 | — | — | — | — | — | 1 | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Brain neoplasms | D001932 | EFO_0003833 | C71 | — | 4 | 3 | — | 2 | 9 |
| Neoplasm metastasis | D009362 | EFO_0009708 | — | — | 3 | 1 | — | 3 | 7 |
| Radiotherapy | D011878 | — | — | — | — | 1 | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Meningeal carcinomatosis | D055756 | EFO_1001012 | — | — | 1 | — | — | 3 | 4 |
| Healthy volunteers/patients | — | — | — | 1 | 1 | — | — | — | 2 |
| Liver diseases | D008107 | EFO_0001421 | K70-K77 | 1 | 1 | — | — | — | 2 |
| Adenosquamous carcinoma | D018196 | — | — | — | 1 | — | — | — | 1 |
| Adenocarcinoma of lung | D000077192 | — | — | — | 1 | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Pharmacokinetics | D010599 | — | — | 1 | — | — | — | — | 1 |
| Hepatic insufficiency | D048550 | — | — | 1 | — | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Second primary neoplasms | D016609 | — | — | — | — | — | — | 1 | 1 |
| Laron syndrome | D046150 | Orphanet_633 | E34.321 | — | — | — | — | 1 | 1 |
| Residual neoplasm | D018365 | — | — | — | — | — | — | 1 | 1 |
| Drug common name | Aumolertinib |
| INN | aumolertinib |
| Description | Almonertinib is an unknown pharmaceutical. It is currently being investigated in clinical studies. It is known to target epidermal growth factor receptor. |
| Classification | Unknown |
| Drug class | tyrosine kinase inhibitors: epidermal growth factor receptor (EGFR) inhibitors |
| Image (chem structure or protein) | ![]() |
| Structure (InChI/SMILES or Protein Sequence) | C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C4CC4)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C |
| PDB | — |
| CAS-ID | 1899921-05-1 |
| RxCUI | — |
| ChEMBL ID | CHEMBL4594354 |
| ChEBI ID | — |
| PubChem CID | 121280087 |
| DrugBank | DB16640 |
| UNII ID | T4RS462G19 (ChemIDplus, GSRS) |
